Mayo Clinic | New hope for patients with metastatic prostate cancer @MayoClinic | Uploaded September 2024 | Updated October 2024, 5 days ago.
Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC).
This treatment involves a radiopharmaceutical known as Pluvicto. It acts like a smart missile, targeting and eliminating cancer cells.
Mayo Clinic experts offer this therapy for patients whose prostate cancer has spread and is resistant to standard treatments such as hormonal treatments and chemotherapy.
Dr. Oliver Sartor, a Mayo Clinic medical oncologist focused on prostate cancer, says Mayo Clinic is at the forefront of treating patients with this novel therapy, offering new options and hope for patients with advanced prostate cancer. He explains what this means.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic
Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC).
This treatment involves a radiopharmaceutical known as Pluvicto. It acts like a smart missile, targeting and eliminating cancer cells.
Mayo Clinic experts offer this therapy for patients whose prostate cancer has spread and is resistant to standard treatments such as hormonal treatments and chemotherapy.
Dr. Oliver Sartor, a Mayo Clinic medical oncologist focused on prostate cancer, says Mayo Clinic is at the forefront of treating patients with this novel therapy, offering new options and hope for patients with advanced prostate cancer. He explains what this means.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic
